Helix Therapeutics, LLC — Form D
Helix Therapeutics, LLC of NEW HAVEN, CT, a company, filed a Form D exempt-offering notice with the SEC on 2010-12-03. The offering totals $3.5M, of which $2.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2010-12-03
- Form: D
- Accession: 0001458721-10-000003
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $3.5M
- Amount sold: $2.5M
- Remaining: $1.0M
- Investors: 2
- Date of first sale: 2010-11-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-151384
Issuer
- Name: Helix Therapeutics, LLC
- CIK: 0001458721
- Entity type: Limited Liability Company
- Jurisdiction: CT
- Incorporated: 2006
- Address: 25 SCIENCE PARK, NEW HAVEN, CT, 06511
- Phone: (203) 980-2461
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Joseph Catino | Director | Guilford, CT |
| Peter Glazer | Director | New Haven, CT |
| Kevin Rakin | Director | New Haven, CT |
| Timothy Shannon | Director | Stamford, CT |
| Russell Tweeddale | Director | Rocky Hill, CT |
| Joseph Catino | Executive Officer | Guilford, CT |
| Ranjit Bindra | Promoter | New Haven, CT |
| Peter Glazer | Promoter | New Haven, CT |
| Kevin Rakin | Promoter | New Haven, CT |
| Gerald Vovis | Promoter | New Haven, CT |
| Kevin Rakin | Executive Officer | New Haven, CT |
| Ranjit Bindra | Director | New Haven, CT |
| Gerald Vovis | Executive Officer | New Haven, CT |
Other filings by this issuer (1)
More